The only treatment for celiac disease is strict adherence to a gluten-free diet and, in an ideal world, compliance with this treatment would reverse all symptoms and physical attributes of the disease (i.e. damage to the small intestine). Unfortunately, that is not always the case; many patients continue to experience a wide range of symptoms and, in some cases, persistent intestinal damage in the form of villous atrophy (flattened villi). Researchers at Columbia University sought to more closely analyze these cases.
5/23/2017
Medication Use Associated with Persistent Villous Atrophy
Recent Posts
- Celiac Disease Foundation Awards $300,000 Grant for Research Shedding Light on Autoantibody Formation in Celiac Disease
- FDA Approves GlutenID: What It Means for Celiac Disease Screening
- Celiac Disease Foundation Champions Change through Global Collaboration on Food Policy
- Dr. Maureen Leonard Appointed Director of the Center for Celiac Research and Treatment at Mass General for Children
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Recipes
- Research
- Research News
- Research Press
- Trending Topics
Marilyn's Message
9/26/2024
Read more2024 International Celiac Disease Symposium Recap